Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00003556 · ClinicalTrials.gov registry record · Phase 1

Vaccine Therapy in Treating Patients With Melanoma

A Phase 1 study of Melanoma (Skin), sponsored by National Cancer Institute (NCI).

Completed
Registry status
Phase 1
Development phase
15
Enrollment target
1
Study location

NCT00003556 is a Phase 1 study of Melanoma (Skin) that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 15 participants, below the 137-participant average among 30 other Melanoma (Skin) trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00003556, a Phase 1 study of Melanoma (Skin), has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
Phase 1
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

Phase I trial to study the effectiveness of vaccine therapy in treating patients with melanoma that cannot be treated with surgery. Vaccines may make the body build an immune response that may kill tumor cells. Combining more than one vaccine may kill more tumor cells.

Conditions Studied

Melanoma (Skin)

Interventions

  • BIOLOGICAL ALVAC-hB7.1
  • BIOLOGICAL canarypox-hIL-12 melanoma vaccine

Study Locations (1)

Alabama

  • University of Alabama Comprehensive Cancer Center - Birmingham

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 1999-01
Phase Phase 1

Sponsor

National Cancer Institute (NCI)

3,257 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00003556

The ClinicalTrials.gov registry entry for NCT00003556 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 137-participant average among 30 other Melanoma (Skin) trials with a reported enrollment target (89% lower). The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Melanoma (Skin) appearing as the primary indexed condition, and to 2 interventions - of which ALVAC-hB7.1 is the first listed.

NCT00003556 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT00003556 about?

NCT00003556 is a clinical study titled "Vaccine Therapy in Treating Patients With Melanoma". Phase I trial to study the effectiveness of vaccine therapy in treating patients with melanoma that cannot be treated with surgery. Vaccines may make the body build an immune response that may kill tumor cells. Combining more than one vaccine may kill more tumor cells.

What is the current status of trial NCT00003556?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 1999-01.

What conditions does trial NCT00003556 study?

This clinical trial studies the following conditions: Melanoma (Skin).

What interventions are being tested in trial NCT00003556?

The interventions under investigation include: ALVAC-hB7.1 (BIOLOGICAL), canarypox-hIL-12 melanoma vaccine (BIOLOGICAL).

Who is sponsoring clinical trial NCT00003556?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00003556 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Melanoma (Skin)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Melanoma (Skin)

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.